The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1975, 114: 244-249.
Copyright © 1975 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blasecki, J. W.
Right arrow Articles by Tevethia, S. S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Blasecki, J. W.
Right arrow Articles by Tevethia, S. S.

In Vitro Studies on the Cellular Immune Response of Tumor-Bearing Mice to SV40-Transformed Cells1

John W. Blasecki and Satvir S. Tevethia

Department of Pathology and Cancer Research Center, Tufts University School of Medicine, Boston, Massachusetts 02111

Abstract

Specific cell-mediated immunity to SV40 tumor-specific transplantation antigen (TSTA) in mice undergoing tumorigenesis by syngeneic SV40-transformed BALB/c cells was investigated by the macrophage migration inhibition (MMI) and transplantation rejection tests. Specific cellular reactivity to SV40 TSTA could be demonstrated in BALB/c mice early after tumor cell inoculation. This activity was no longer detectable during the later stages of tumor growth but was again demonstrable 2 weeks after tumor excision. Addition of an equal number of non-reactive peritoneal exudate (PE) cells from tumor-bearing mice to PE cells from mice immune to SV40 TSTA specifically abrogated the reactivity of the latter cells to soluble SV40 TSTA. When lymphoid cells with blocking activity were cultured in vitro they not only lost their blocking capacity but also regained their reactivity to SV40 TSTA in the MMI test. These findings indicate that tumor-bearing hosts possess lymphocytes specifically sensitized to the TSTA of the tumor and that the specific reactivity of these cells can be regained after culture in vitro.

Footnotes

1 This study was supported by research Grants CA 14939 and CA 12924, from the National Cancer Institute, National Institutes of Health.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1975 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1975 by The American Association of Immunologists, Inc. All rights reserved.